Brain sweet brain: Importance of sugars for the cerebral microenvironment and tumor development;Cérebro doce cérebro: Importância dos açúcares para o microambiente cerebral e o desenvolvimento tumoral

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 5, 2010, Pages 799-803

  Quirico Santos, Thereza ^a   Fonseca, Clovis O ^b   Lagrota Candido, Jussara ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

Author keywords

Brain microenvironment; Extracellular matrix; Glioma; Glycoproteins

Indexed keywords

AGGRECAN; AMPA RECEPTOR; BREVICAN; COLLECTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GALECTIN 1; GALECTIN 3; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HEPARAN; HYALURONIC ACID; NEUROCAN; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; RAS PROTEIN; VERSICAN;

BRAIN DEVELOPMENT; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL DEATH; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; GLIA; HOMEOSTASIS; HUMAN; LONG TERM POTENTIATION; MICROENVIRONMENT; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; ONCOGENE K RAS; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL;

EID: 78649521217     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2010000500024     Document Type: Review

References (37)

1. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003;3:489-501.
2. Park JB, Kwak HJ, Lee SH. Role of hyaluronan in glioma invasion. Cell Adh Migr 2008;2:202-207.
3. Evanko SP, Tammi MI, Tammi RH, Wight TN. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 2007;59:1351-1365.
4. Murphy JF, Lennon F, Steele C, Kelleher D, Fitzgerald D, Long AC. Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells. FASEB J 2005;19:446-448.
5. Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 2004;25:2789-2798.
6. Bonneh-Barkay D, Wiley CA. Brain extracellular matrix in neurodegeneration. Brain Pathol 2009;19:573-585.
7. Galtrey CM, Fawcett JW. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007;54:1-18.
8. Viapiano MS, Matthews RT. From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology. Trends Mol Med 2006;12:488-496.
9. Sim H, Hu B, Viapiano MS. Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas. J Biol Chem 2009;284: 26547-26556.
10. Abaskharoun M, Bellemare M, Lau E, Margolis RU. Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells. Brain Research 2010;23:6-15.
11. Buss A, Pech K, Kakulas BA, et al. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. BMC Neurol 2009; 9:32-47.
12. Bruckner G, Morawski M, Arendt T. Aggrecan-based extracellular ma trixis an integral part of the human basal ganglia circuit. Neuroscience 2008;151:489-504.
13. Pantazopoulos H, Murray EA, Berretta S. Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala. Brain Res 2008;1207:84-95.
14. Morawski M, Bruckner MK, Riederer P, Bruckner G, Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp Neurol 2004;188: 309-315.
15. Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metallo proteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009;158:983-994.
16. Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006;16:137R-157R.
17. Toscano MA, Ilarregui JM, Bianco GA, et al. Dissecting the pathophysiologicrole of endogenous lectins: glycan-binding proteins with cytokine-like activity? Cytokine Growth Factor Rev 2007;18:57-71.
18. Albesiano E, Han JE, Lim M. Mechanisms of local immunoresistance in glioma. Neurosurg Clin N Am 2010;21:17-29.
19. Jung T-Y, Jung S, Ryu H-H, et al. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines. J Neurosurg 2008;109:273-284.
20. Park S-H, Min HS, Kim B, Myung J, Paek SH. Galectin-3: A useful biomarker for differential diagnosis of brain tumors. Neuropathology 2008;28:497-506.
21. Ulrich TA, de Juan Pardo EM, Kumar S. The mechanical rigidity of the extra cellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res 2009;69:4167-4174.
22. Sarkar S, Yong VW. Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix. Carcinogenesis 2010;31:311-317.
23. Heimberger AB, Hlatky R, Suki D, et al. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res 2005;11:1462-1466.
24. Goldberg L, Kloog Y. A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration. Cancer Res 2006;66:11709-11717.
25. Ashery U, Yizhar O, Rotblat B, et al. Spatiotemporal organization of Rassig naling: rasosomes and the galectin switch. Cell Mol Neurobiol 2006;26: 471-495.
26. Nickl-Jockschat T, Arslan F, Doerfelt A, Bogdahn U, Bosserhoff A, Hau P. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas. Int J Oncol 2007;30:499-507.
27. Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Mutant p53: an oncogenic transcription factor. Oncogene 2007;26: 2212-2219.
28. Le Mercier M, Mathieu V, Haibe-Kains B, et al. Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. J Neuropathol Exp Neurol 2008;67:456-469.
29. Kovács-Sólyom F, Blaskó A, Fajka-Boja R, et al. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunology Letters 2010;127:108-118.
30. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005;5:29-41.
31. Saussez S, Lorfevre F, Lequeux T, et al. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol 2008;44:86-93.
32. Neder L, Marie SK, Carlotti Jr. CG, et al. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. Brain Pathol 2004; 14:399-405.
33. Brat DJ, Castellano-Sanchez AA, Hunter SB, et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 2004;64: 920-927.
34. Gondi CS, Dinh DH, Gujrati M, Rao JS. Simultaneous downregulation of 34. uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas. Int J Oncol 2008;33:783-790.
35. Wu Y, Chen L, Zheng PS, Yang BB. Beta 1-Integrin-mediated glioma cell ad35. hesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem 2002;277:12294-12301.
36. Ricciardelli C, Sakko AJ, Ween MP, Russell DL, Horsfall DJ. The biological role 36. and regulation of versican levels in cancer. Cancer Metastasis Rev 2009; 28:233-245.
37. Liu S, Tian Z, Yin F, et al. Expression and functional roles of Smad1 and BM37. PR-IB in glioma development. Cancer Invest 2009;27:734-740.